Global Women’s Health Market Size by Growth Rate, Business Challenges, Competitors, and Forecast 2027 | Emergen Research
The global women’s health market is expected to reach USD 24.48 Billion by 2027, according to a new report by Emergen Research. The women’s healthcare market is experiencing high demand attributable to a growing demand for devices (intrauterine devices, vaginal rings, and implants) and drugs (Prolia, Evista, Xgeva, Mirena, and Zometa, among others) in applications comprising contraceptives, postmenopausal osteoporosis, hormonal infertility, menopause, endometriosis, and polycystic ovary syndrome (PCOS), among others.
Use of female
contraception is beneficial in the prevention of health issues associated with
pregnancy, particularly for pubescent girls, as well as in pregnancy planning
to reduce the chances of infant mortality, which is higher in childbirths
separated by a lesser number of years. Besides, it provides various other
prospective benefits comprising prolonged prospects for education and women
empowerment, along with maintaining a healthy population and economic growth of
nations.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/91
Some
Key Highlights from the Report
·
By product type, devices held a substantial women’s health
market share in 2019. The introduction of minimally invasive methods has
escalated the demand for several surgical procedures amid the women population.
Also, a growing trend among female patients’ towards technologically advanced
techniques for treatment is the causative of market growth.
·
By application, hormonal infertility is projected to grow at the
fastest rate of 13.6% in the forecast period. High levels of FSH
(follicle-stimulating hormone) in female blood may decrease the chances of
conceiving. Also, abnormal estradiol, a kind of estrogen hormone, levels may
reduce the possibility of success in vitro fertilization (IVF).
·
By end-users, research institutes are projected to grow at the
fastest rate in the forecast period. Various research institutes such as the
Women's Health Research Institute (WHRI) undertake several research activities
to improve the health of women, especially reproductive health. Academic
research institutes carry out many R&D activities to develop novel drugs
and devices, which would fuel the market growth in the upcoming years.
Regional Analysis Covers:
·
North America (U.S., Canada)
·
Europe (U.K., Italy, Germany, France, Rest of EU)
·
Asia Pacific (India, Japan, China, South Korea,
Australia, Rest of APAC)
·
Latin America (Chile, Brazil, Argentina, Rest of
Latin America)
·
Middle East & Africa (Saudi Arabia, U.A.E.,
South Africa, Rest of MEA)
Competitive
Landscape:
The latest study provides an insightful analysis of the broad
competitive landscape of the global Women’s Health market, emphasizing the key
market rivals and their company profiles. A wide array of strategic
initiatives, such as new business deals, mergers & acquisitions,
collaborations, joint ventures, technological upgradation, and recent product
launches, undertaken by these companies has been discussed in the report. The report analyzes
various elements of the market’s competitive scenario, such as the regulatory
standards and policies implemented across the industry over recent years. Our
team of experts has leveraged several powerful analytical tools, such as
Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive
overview of the global Women’s Healthmarket and pinpoint the fundamental growth
trends.
Key participants include Merck & Co., Allergan, Bayer AG,
Novartis AG, Pfizer, Amgen, Lupin Limited, Johnson & Johnson Services Inc.,
Agile Therapeutics, and Apothecus Pharmaceutical Corporation, among others.
Market
Overview:
The report bifurcates
the Women’s Healthmarket on the basis of different product types, applications,
end-user industries, and key regions of the world where the market has already
established its presence. The report accurately offers insights into the
supply-demand ratio and production and consumption volume of each segment.
Request customization
of the report https://www.emergenresearch.com/request-for-customization/91
Emergen Research has segmented the global women’s health market
on the basis of product type, application, end-users, and region:
Product
Type Outlook (Revenue, USD Billion; 2017-2027)
·
Devices
·
Drugs
Application
Outlook (Revenue, USD Billion; 2017-2027)
·
Contraceptives
·
Postmenopausal Osteoporosis
·
Hormonal Infertility
·
Menopause
·
Endometriosis
·
Polycystic Ovary Syndrome (PCOS)
·
Others
End
Users Outlook (Revenue, USD Billion; 2017-2027)
·
Hospitals & Clinics
·
Obstetrics & Gynecology Centers
·
Ambulatory Surgical Centers
·
Research Institutes
·
Others
Unfolding the prime factors prompting global
market growth:
·
The study offers an in-depth
analysis of the product outlook, which depicts the latest production growth trends
and profit valuation. It further fragments the global Women’s Health market
into a broad product spectrum.
·
The study covers essential data
related to these products’ application landscape, the demand for and market
share held by each application type, and their growth rate analysis over the
estimated period.
·
A detailed description of the
distribution channels, including distributors, producers, and buyers, is one of
the report’s key market highlights.
Thank you for reading our report. Customization of this
report is available in chapter-wise or region-wise sections. Kindly get in
touch with us to know more about the report, and our team will provide
excellent assistance.
To
know more about the report, visit @ https://www.emergenresearch.com/industry-report/womens-health-market
About
Us:
At Emergen Research, we believe in advancing with technology. We are a
growing market research and strategy consulting company with an exhaustive
knowledge base of cutting-edge and potentially market-disrupting technologies
that are predicted to become more prevalent in the coming decade.
Contact Us:
Corporate Sales Specialist
Emergen Research |
Web: www.emergenresearch.com
Direct Line: +1
(604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Comments
Post a Comment